StockData
Odyssey Health, Inc. logo

Odyssey Health, Inc. (ODYY) company profile

ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 0/30
$0.01−0.00 (-16.25%)

Close on Oct 19, 2026Market cap $746.34KP/E –Yield –

About Odyssey Health

Surgical & Medical Instruments & Apparatus, SIC 3841

Odyssey Health, Inc. is a medical technology company focused on acquiring and developing medical devices and technologies designed to address unmet clinical needs. The company operates across a single business segment and is developing two primary product candidates: CardioMap, a non-invasive heart monitoring and screening device intended to detect early signs of coronary heart disease, and Save-A-Life, an emergency choking rescue device designed to clear lodged obstructions from a victim's throat using vacuum suction. Odyssey Health does not currently market or sell any products commercially, as its technologies remain in development and require regulatory clearances, such as Food and Drug Administration approvals, prior to commercialization.

The company's planned end users include cardiologists, physicians, clinics, hospitals, sports teams, emergency facilities, and the general public, with prospective commercial distribution structured through industry partners and qualified distributors. Odyssey Health maintains its principal executive offices in Las Vegas, Nevada, and employs two individuals.

Summary of the business section of Odyssey Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Odyssey Health, Inc.
Founded
2014
Headquarters
Las Vegas, NV
Address
2300 West Sahara Avenue, Suite 800-#4012 89102
Phone
(702) 780-6559
Employees
2, Jul 31, 2026
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Nevada
Fiscal year ends
July 31
Auditor
Turner, Stone & Company, L.L.P., Dallas, Texas

Stock & identifiers

Ticker
ODYY
Exchange
OTC
Shares outstanding
110M, Oct 27, 2026
Public float
$6.20M, Jan 31, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1626644
FIGI
BBG007QQ7F07
Share class FIGI
BBG007QQ7F16
EIN
47-1022125

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Odyssey Health's leadership is listed in its proxy statement, last filed Oct 30, 2023.

Employees

Headcount reported in annual reports

“At the date hereof, we have two employees and do not intend to hire additional employees in the foreseeable future.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 30, 2024Late filingNotification of late filing
Mar 18, 2024Late filingNotification of late filing
Dec 29, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 18, 2022Name changeName changed from Odyssey Group International, Inc. to Odyssey Health, Inc.
Jun 14, 2021Late filingNotification of late filing
Oct 29, 2020Late filingNotification of late filing
Oct 27, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 6, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Oct 29, 2018Late filingNotification of late filing
Jun 13, 2018Late filingNotification of late filing
Mar 21, 2018Late filingNotification of late filing
Dec 12, 2017Late filingNotification of late filing
Oct 30, 2017Late filingNotification of late filing
Jun 14, 2017Late filingNotification of late filing
Mar 14, 2017Late filingNotification of late filing
Dec 13, 2016Late filingNotification of late filing
Nov 1, 2016Late filingNotification of late filing
Jun 14, 2016Late filingNotification of late filing
Dec 15, 2015Late filingNotification of late filing

See a number that looks wrong?